Aequus Pharmaceuticals Inc (AQS):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Aequus Pharmaceuticals Inc (AQS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8289
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:64
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Aequus Pharmaceuticals Inc (Aequus Pharmaceuticals) is a drug discovery and development company that develops differentiated drugs. The company’s pipeline products include AQS301, AQS302 and AQS303. Its commercial pipeline comprises ophthalmology products and transplant products. Aequus Pharmaceuticals develops products in the areas of neurology and psychiatry with addressing the need for improved medication through enhanced delivery systems. The company offers its products to hospital specialty markets including patented products, branded generics, and reformulated novel-delivery products within focused therapeutic areas across Canada. It offers its products in therapeutic areas such as ophthalmology, neurology, and transplant. Aequus Pharmaceuticals is headquartered in Vancouver, British Columbia, Canada.

Aequus Pharmaceuticals Inc (AQS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Aequus Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
Aequus Pharma Raises USD0.6 Million in Venture Financing 13
Aequus Pharma Raises US$1.2 Million In First Round Of Venture Financing 14
Partnerships 15
Aequus Pharma Enters into Agreement with Ehave 15
CannaRoyalty and Aequus Pharma Enter into Agreement 16
Aequus Pharma to Enter into Agreement with Scientus Pharma 17
Aequus Pharma Enters into Agreement with Santen 18
Aequus Pharma and Centre for Drug Research and Development Enter into a Research Agreement 19
Aequus Pharma Enters into Co-Development Agreement with Corium International 20
Aequus Pharma Enters into Co-Development Agreement with Corium International 21
Licensing Agreements 22
Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 22
Aequus Pharma Enters into Licensing Agreement with Supernus Pharma 23
Aequus Pharma Enters Into Licensing Agreement With Transdermal Research Pharm Labs For Transdermal Delivery Of Aripiprazole 24
Equity Offering 25
Aequus Pharma Raises USD0.2 Million in Private Placement of Units 25
Aequus Pharma Raises USD0.6 Million in Private Placement of Units 26
Aequus Raises USD0.2 Million in Private Placement of Units 28
Aequus Pharma Plans to Raise up to USD15.7 Million in Public Offering 29
Aequus Pharma Raises USD3.9 Million in Public Offering of Units 30
Aequus Pharma Raises USD2 Million in Public Offering of Shares 32
Aequus Pharma Raises USD1.3 Million in Public Offering of Shares 33
Aequus Pharma Raises USD0.6 Million in Private Placement of Shares 34
Aequus Pharma Raises USD1 Million in Public Offering of Shares 35
Aequus Pharma Raises USD3.3 Million in Private Placement of Warrants 36
Aequus Pharma Raises USD0.4 Million in Private Placement of Warrants 37
Acquisition 38
Aequus Pharma Acquires TeOra Health 38
Aequus Pharmaceuticals Inc – Key Competitors 39
Aequus Pharmaceuticals Inc – Key Employees 40
Aequus Pharmaceuticals Inc – Locations And Subsidiaries 41
Head Office 41
Other Locations & Subsidiaries 41
Recent Developments 42
Financial Announcements 42
May 31, 2018: Aequus Provides First Quarter 2018 Financial and Corporate Highlights 42
Apr 27, 2018: Aequus Pharmaceuticals Reports Fourth Quarter and Fiscal 2017 Financial Highlights 44
Nov 29, 2017: Aequus Provides Third Quarter 2017 Operational Highlights 47
Aug 29, 2017: Aequus Provides Second Quarter 2017 Operational Highlights 49
May 30, 2017: Aequus Provides First Quarter 2017 Financial Highlights 51
May 01, 2017: Aequus Provides Fourth Quarter and Fiscal 2016 Financial Highlights 52
Product News 54
09/07/2017: Aequus Announces Positive Results for Proof of Concept Clinical Trial of Anti-Nausea Patch 54
04/03/2017: Aequus Announces Positive Results from Second Proof of Concept Study for Long-Acting Aripiprazole Transdermal Patch 55
02/01/2017: Aequus Receives Non-Dilutive Funding from the Government of Canada to Support Aripiprazole Patch Development 56
Product Approvals 57
Mar 07, 2018: FDA Confirms Date to Providing Regulatory Guidance for Aequus’ Anti-Nausea Patch 57
Jan 31, 2018: Aequus and Camargo Prepare for Meeting with FDA to Advance Anti-Nausea Patch 58
Aug 24, 2017: Aequus Announces Abbreviated Development Path for Transdermal Aripiprazole 59
Jun 15, 2017: Aequus Advances Clinical Development of Transdermal Anti-Nausea Patch 60
Jan 09, 2017: Aequus Initiates Second Proof of Concept Clinical Trial of Transdermal Aripiprazole Patch 61
Clinical Trials 62
Jul 05, 2017: Aequus Receives Approval from Health Canada to Initiate Proof of Concept Clinical Trial of Anti-Nausea Patch 62
Feb 14, 2017: Aequus Successfully Completes Dosing in Second Proof of Concept Clinical Trial of Transdermal Aripiprazole Patch 63
Appendix 64
Methodology 64
About GlobalData 64
Contact Us 64
Disclaimer 64

List of Tables
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Aequus Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Aequus Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Aequus Pharma Raises USD0.6 Million in Venture Financing 13
Aequus Pharma Raises US$1.2 Million In First Round Of Venture Financing 14
Aequus Pharma Enters into Agreement with Ehave 15
CannaRoyalty and Aequus Pharma Enter into Agreement 16
Aequus Pharma to Enter into Agreement with Scientus Pharma 17
Aequus Pharma Enters into Agreement with Santen 18
Aequus Pharma and Centre for Drug Research and Development Enter into a Research Agreement 19
Aequus Pharma Enters into Co-Development Agreement with Corium International 20
Aequus Pharma Enters into Co-Development Agreement with Corium International 21
Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 22
Aequus Pharma Enters into Licensing Agreement with Supernus Pharma 23
Aequus Pharma Enters Into Licensing Agreement With Transdermal Research Pharm Labs For Transdermal Delivery Of Aripiprazole 24
Aequus Pharma Raises USD0.2 Million in Private Placement of Units 25
Aequus Pharma Raises USD0.6 Million in Private Placement of Units 26
Aequus Raises USD0.2 Million in Private Placement of Units 28
Aequus Pharma Plans to Raise up to USD15.7 Million in Public Offering 29
Aequus Pharma Raises USD3.9 Million in Public Offering of Units 30
Aequus Pharma Raises USD2 Million in Public Offering of Shares 32
Aequus Pharma Raises USD1.3 Million in Public Offering of Shares 33
Aequus Pharma Raises USD0.6 Million in Private Placement of Shares 34
Aequus Pharma Raises USD1 Million in Public Offering of Shares 35
Aequus Pharma Raises USD3.3 Million in Private Placement of Warrants 36
Aequus Pharma Raises USD0.4 Million in Private Placement of Warrants 37
Aequus Pharma Acquires TeOra Health 38
Aequus Pharmaceuticals Inc, Key Competitors 39
Aequus Pharmaceuticals Inc, Key Employees 40
Aequus Pharmaceuticals Inc, Subsidiaries 41

List of Figures
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Aequus Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Aequus Pharmaceuticals Inc (AQS):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Incitec Pivot Ltd (IPL):企業の財務・戦略的SWOT分析
    Incitec Pivot Ltd (IPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Accugenomics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Accugenomics Inc (Accugenomics) is a developer of oncology molecular diagnostics. The company develops and markets gene expression tests to diagnose and monitor cancer treatment. It offers gene expression tests including lung cancer risk test, standardized BCR-ABL molecular diagnostics test …
  • Teledyne Technologies Incorporated (TDY):企業の財務・戦略的SWOT分析
    Teledyne Technologies Incorporated (TDY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • ASIT Biotech SA (ASIT):製薬・医療:M&Aディール及び事業提携情報
    Summary ASIT Biotech SA (ASIT Biotech), formerly BioTech Tools SA is a clinical stage biopharmaceutical company that develops in-vitro and in-vivo biotech tools. The company develops and commercializes immunotherapy medicines for respiratory and food allergies using ASIT plus technology platform. It …
  • LiNiu Technology Group:企業の戦略・SWOT・財務分析
    LiNiu Technology Group - Strategy, SWOT and Corporate Finance Report Summary LiNiu Technology Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Petromin Resources Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Petromin Resources Ltd (Petromin) is an oil and gas exploration and production company that acquires, explores, develops and produces petroleum and natural gas. The company’s projects include Gilby, Redwater, Frog Lake and MorningSide projects in Alberta, Canada. It also explores and develop …
  • Daiho Corporation
    Daiho Corporation - Strategy, SWOT and Corporate Finance Report Summary Daiho Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Singapore Power Limited:企業の戦略・SWOT・財務分析
    Singapore Power Limited - Strategy, SWOT and Corporate Finance Report Summary Singapore Power Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Polaris Industries Inc.:企業の戦略・SWOT・財務情報
    Polaris Industries Inc. - Strategy, SWOT and Corporate Finance Report Summary Polaris Industries Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Hindustan Petroleum Corporation Limited:企業の戦略・SWOT・財務情報
    Hindustan Petroleum Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Hindustan Petroleum Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Adynxx Inc (ADYX):企業の財務・戦略的SWOT分析
    Summary Adynxx Inc (Adynxx), formerly known as Alliqua BioMedical, Inc, is a clinical stage biopharmaceutical company. It utilizes AYX transcription factor decoys to create therapies with disease changing properties. The company is involved in the development of transcription factor decoy technology …
  • MSCI Inc (MSCI):企業の財務・戦略的SWOT分析
    MSCI Inc (MSCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • The Petroleum Oil and Gas Corporation of South Africa (SOC) Ltd:企業の戦略的SWOT分析
    The Petroleum Oil and Gas Corporation of South Africa (SOC) Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employee …
  • Sanwa Kagaku Kenkyusho Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Sanwa Kagaku Kenkyusho Co Ltd (Sanwa), a subsidiary of Suzuken Co Ltd is a contract manufacturing company that conducts research, manufactures and commercializes of pharmaceutical drugs for treating diagnostics, healthcare products, and medical and nursing care nutritionals. The company also …
  • Drugs for Neglected Diseases initiative:製薬・医療:M&Aディール及び事業提携情報
    Summary Drugs for Neglected Diseases initiative (DNDi) is a non-profit drug research and development (R&D) organization which discovers and develops new drugs for neglected diseases. The organization develops therapeutics for the treatment of various diseases such as human African trypanosomiasis (H …
  • Alliant Credit Union:企業の戦略的SWOT分析
    Alliant Credit Union - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Independent Petroleum Group (IPG):企業の財務・戦略的SWOT分析
    Independent Petroleum Group (IPG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Fresenius SE & Co KGaA (FRE):医療機器:M&Aディール及び事業提携情報
    Summary Fresenius SE & Co KGaA (Fresenius) is a global health care group, which offers products and services for dialysis treatment. It provides various dialysis services through its own clinics and sells its products to other dialysis service providers. Its major products and services includes mach …
  • 3i Infotech Ltd (3IINFOTECH):企業の財務・戦略的SWOT分析
    3i Infotech Ltd (3IINFOTECH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Saudi Industrial Services Co (2190):企業の財務・戦略的SWOT分析
    Summary Saudi Industrial Services Co (SISCO) is an investment holding company that develops and invests in the water, wastewater, energy, IT, sewage, and communications business. The company undertakes large scale capital investment in desalination plants, industrial estate development, free zone po …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆